2025 Partners
The Jackson Laboratory
Expertise Partner
The JAX Center for Biometric Analysis (CBA) is a state-of-the-art, ~21,000-ft dedicated facility providing scientists with extensive facilities and expertise to perform in vivo mouse phenotyping, i.e., observation and measurement of mouse characteristics, spanning a broad range of biological domains and disease states. We can interrogate phenotypes deeply, measuring extremely subtle signs of disease. Complementing this, we have the capacity to perform phenotyping at high throughput and large scale.
Antaros Medical
Expertise Partner
Antaros Medical is pioneering imaging methods, using MRI* and PET**, to both design and deliver clinical imaging studies. Applied with our extensive experience and expertise in drug development and disease biology, our tailored solutions have helped our customers to solve complex problems to empower confident decision-making at every stage of clinical drug development, from small mechanistic studies to large scale studies. Disease areas: CV, renal & metabolic diseases and oncology.
Perspectum
Expertise Partner
Perspectum is an innovative company pushing the frontier of personalized medicine through our advanced non-invasive imaging portfolio. Working across the obesity and metabolic disease space, our best-in-class precision health technology provides sponsors with tangible insights into the mechanisms and benefits of their incretin-based treatments. Working across the entire development pipeline, we support sponsors to differentiate their treatments by allowing them to see and quantify more than ever before.
AMRA Medical
Expertise Partner
AMRA Medical is a health informatics and precision medicine company that is pioneering body composition analysis, providing cutting-edge solutions to advance both clinical research and patient care initiatives. AMRA's gold-standard technology delivers multiple fat and muscle biomarkers - derived simply from rapid whole-body MRI scans. AMRA is committed to driving transformative care and simplifying vital decision-making in both research and clinical settings by offering support services via their innovative platform to help advance disease research in obesity and beyond.
Promega
Innovation Partner
Promega is committed to excellence in technologies and compound profiling services to assess key processes in Targeted Protein Degradation and Induced Proximity mechanisms. From assessing protein degradation in real time, to understanding compound binding and permeability, to ternary complex formation and more. Our CRIPSR HiBiT content covers hundreds of pre-built targets. Novel software analysis tools allow for the determination of target protein degradation rates, DC50 potency values, recovery profiles and more.
National Academy of Sports Medicine
Hosting Partner
The National Academy of Sports Medicine (NASM) is an organization that provides certification, education, and career development opportunities for professionals in the fitness, wellness, and sports industries. NASM has gained recognition for its evidence-based approach to fitness and wellness education and has developed a range of programs aimed at enhancing the skills of personal trainers, wellness coaches, athletic trainers, strength and conditioning coaches, physical therapists, and other health professionals.
ICON
Hosting Partner
ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,900 employees in 106 locations in 55 countries as at December 31, 2024.
AnaSpec
Event Partner
AnaSpec is a U.S. manufacturer of Peptides and Peptidomimetics, with over 30 years of expertise in complex to simple peptides and peptide libraries. Globally recognized for quality and product excellence, we serve the biopharmaceutical industry, diagnostic companies, agro-food firms, academia, and governmental institutions. Our custom manufacturing capabilities cover every stage of the product lifecycle—from R&D through GMP-grade production for clinical applications. GLP-1 off-the-shelf research-use peptides are also available from our large catalog portfolio.
Cardiomedex
Event Partner
Cardiomedex is a preclinical CRO, highly specialized in cardiovascular and cardiometabolic diseases in collaboration with its affiliates company Physiogenex, specialized in metabolic diseases (obesity/type 2 diabetes & comorbidities). Cardiomedex provides reliable preclinical studies using integrative predictive models of HFpEF , HFrEF, cardiac hypertrophy & fibrosis, myocardial infarction, cardiomyopathy (takotsubo, genetic..), cardiometabolic diseases, hypertension, cardiotoxicity, etc. and new tailor-made models to fulfil our partners’ needs. Cardiomedex offers ex-vivo (vascular reactivity/isolated heart/cardiomyocytes/mitochondrial function) and in-vivo exploration (echocardiography/telemetry/PV loops/ECG/treadmill/tail cuff) to provide in-depth functional characterization.